Clinical Trial Update: Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intra-erythrocyte dexamethasone sodium phosphate in patients with Ataxia Telangiectasia has completed and results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• Intra-Erythrocyte Dexamethasone Sodium Phosphate (dexamethasone sodium phosphate)

Snippet

Sponsor: Quince Therapeutics S.p.A. | Conditions: Nervous System Disease, Genetic Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-05-09